Evidence map›Paper›PMID 40630029›Full record

ArticlePhytochemical analysis : PCA2025

Call for Standardizing Uncaria rhynchophylla as the Sole Origin of Uncariae Ramulus cum Uncis.

Hau-Yee Fung, Cheuk-Hei Lai, Qianran Li, Hau-Yee Kong, Lifeng Li, Quanbin Han

Abstract read
In one paragraph

Article in Phytochemical analysis : PCA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hau-Yee FungSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Cheuk-Hei LaiSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Qianran LiSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Hau-Yee KongSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Lifeng LiSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
Quanbin HanSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.ORCID https://orcid.org/0000-0001-9051-1485

Funding

General Research Fund 12100615General Research Fund 12100818General Research Fund 12101123General Research Fund 12101322General Research Fund 22100014Health and Medical Research Fund 11122531Health and Medical Research Fund 14150521Health and Medical Research Fund 17182681Hong Kong Baptist University FRG2/16-17/002Hong Kong Baptist University FRG2/17-18/060Hong Kong Baptist University MPCF-001-2016/2017Hong Kong Baptist University RC-IRMS/14-15/06Hong Kong Baptist University RC-Start-up GrantsHong Kong Chinese Materia Medica StandardsInnovation and Technology Fund Tier 3, ITS/311/09Key-Area Research and Development Program of Guangdong Province 2020B1111110007National Natural Sciences Foundation in China 81473341National Natural Sciences Foundation in China 82173948National Natural Sciences Foundation in China 82204747Science and Technology Project of Shenzhen JCYJ20160531193812867UGC Research Matching Grant Scheme 2019-1-10UGC Research Matching Grant Scheme 2019-1-14UGC Research Matching Grant Scheme 2019-2-06Vincent & Lily Woo Foundation
6 · The paper itself

Abstract

backgroundUncariae Ramulus cum Uncis (URCU) is a widely used traditional Chinese medicine (TCM) for treating neurodegenerative disorders. The Chinese Pharmacopeia recognizes five Uncaria species as authorized botanical sources of URCU; however, there is currently no established quality control method for individual species. Furthermore, significant variations in the chemical profiles among these species have been reported.

objectiveChemical analysis methods were established to evaluate the five species in terms of chemical profile and resource availability, as to determine which species should be preferred as the official source(s).

methodTen batches of URCU sample were collected from various regions of China for each of the five species of URCU. Among five species, only UR can be obtained from herbal medicine market, whereas the other four species were sourced from the wild. All samples identities were confirmed by herbarium specimen authentication, morphological identification, and microscopic identification. Twelve alkaloids were identified in the five species, and a UPLC-DAD assay method targeting six marker alkaloids was developed and validated.

resultsOnly UR and UM demonstrated the most stable chemical profiles and agreement with published literature. UR mainly contains corynoxeine, isocorynoxeine, rhynchophylline, and isorhynchophylline, whereas corynoxine, corynoxine B, rhynchophylline, and isorhynchophylline dominate in UM.

conclusionThis study comprehensively evaluated the chemical variations among the five officially recognized URCU species using a UPLC-DAD method. It brings important implications for quality control and standardization of URCU. Considering chemical stability and supply availability, UR is recommended as the sole botanical source for URCU.

Indexed as

Drugs, Chinese HerbalUncariaAlkaloidsCat's ClawChromatography, High Pressure LiquidPlant ExtractsQuality ControlAlkaloidscat's claw extractDrugs, Chinese HerbalPlant Extractschemical variationmonoterpene indole alkaloidsquality controlUncariae Ramulus cum UncisUncaria rhynchophyllaURCU

Identifiers

PMID40630029
PMCPMC12511843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.